Slide 1: Investor Presentation
Investor Presentation We enhance communicatio! collaboration rganizations
Slide 2: Safe-Harbor Statement - 1 of 2
I Safe-Harbor Statement-1 of 2 "hs presentation incudes Torwatd looking lalemens” win the meaning of Section 27 of the Secuiles Act of 1993, a amend, and Secton 21E of he Secuttes Exchange Act ot 1994, as amended (the “Exchange Act) All laiements in is repod, other than Satements of historical fac,
Slide 3: Safe-Harbor Statement - 2 of 2
ClearOne. l Nasdaq:CLRO Safe-Harbor Statement -— 2 of 2 ‘This commurncatio is nol an offer fo Sell ora soeaion of ffs fo purchase any Secures. This communscaton has not been approved of disapproved bythe U.S. Secutles and Exchange Commssion (he "SEC") or the secuties regulatory auhonty of any Sint,
Slide 4: Progress Since 6/14
ClearOne. Nasdaq:CLRO Progress Since 6/14 Investor Update + Total revenue increased by 31% in Q2 2023 compared to Q1 2023 driven by increased shipments of orders from the backlog due to improved manufacturing output. * Achieved sequential and Year-Over-Year OpEx reductions in Q2 2023. + We maintain
Slide 5: Financial Summary — Revenue
Financial Summary — Revenue ClearOne. Nasdaq:CLRO + Revenue performance expected to improve in 2H23 as the Company works to mitigate recent pressures from litigation impacts and manufacturing volume constraints Annual Revenue and Gross Margin arene eae Quarterly Revenue and Gross Margin
Slide 6: Financial Summary — OpEx and Profitability
ClearOne. Nasdaq:CLRO Financial Summary — OpEx and Profitability + Cost-cutting initiatives implemented in FY22 drive operating expense reductions and leaner foundation for growth Annual OpEx Quarterly OpEx rn) * goer ores arza oxze ara onze orm ores FY19 T™M@ a: GAAP Net income (Loss) sem eno Non-G
Slide 7: Balance Sheet
Balance Sheet Inventors (Crent ane oneTerm) Intangibles Total Assets spines “otal abies Equity ‘ceumulatesDeeindusing ACC Total equity “Total abilities & Equity ClearOne. Nasdaq:CLRO
Slide 8: Corporate Focus
f Corporate Focus > Innovation 7 new products introduced in the last 12 months 84 issued patents with additional applications pending > Cost Savings GAAP OPEX reduced by ~29% YoY and 9% sequentially. > Manufacturing Transition and Ramp Revenue growth in Q2 2023 was driven by shipment of orders from